| Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2 JD Hoffert, RA Fenton, HB Moeller, B Simons, D Tchapyjnikov, BW McDill, ... Journal of biological chemistry 283 (36), 24617-24627, 2008 | 260 | 2008 |
| Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING CK Holm, SB Jensen, MR Jakobsen, N Cheshenko, KA Horan, ... Nature Immunology 13 (8), 737-743, 2012 | 255 | 2012 |
| Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment HB Moeller, S Rittig, RA Fenton Endocrine reviews 34 (2), 278-301, 2013 | 214 | 2013 |
| Phosphorylation of aquaporin-2 regulates its endocytosis and protein–protein interactions HB Moeller, J Praetorius, MR Rützler, RA Fenton Proceedings of the National Academy of Sciences 107 (1), 424-429, 2010 | 197 | 2010 |
| Acute regulation of aquaporin-2 phosphorylation at Ser-264 by vasopressin RA Fenton, HB Moeller, JD Hoffert, MJ Yu, S Nielsen, MA Knepper Proceedings of the National Academy of Sciences 105 (8), 3134-3139, 2008 | 162 | 2008 |
| Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells HB Moeller, MA Knepper, RA Fenton Kidney international 75 (3), 295-303, 2009 | 150 | 2009 |
| Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus ETB Olesen, MR Rützler, HB Moeller, HA Praetorius, RA Fenton Proceedings of the National Academy of Sciences 108 (31), 12949-12954, 2011 | 125 | 2011 |
| Differential water permeability and regulation of three aquaporin 4 isoforms RA Fenton, HB Moeller, M Zelenina, MT Snaebjornsson, T Holen, ... Cellular and molecular life sciences 67, 829-840, 2010 | 123 | 2010 |
| Regulation of the water channel aquaporin-2 by posttranslational modification HB Moeller, ETB Olesen, RA Fenton American Journal of Physiology-Renal Physiology 300 (5), F1062-F1073, 2011 | 117 | 2011 |
| Cell biology of vasopressin-regulated aquaporin-2 trafficking HB Moeller, RA Fenton Pflügers Archiv-European Journal of Physiology 464, 133-144, 2012 | 87 | 2012 |
| Aquaporins in the kidney TH Kwon, J Nielsen, HB Møller, RA Fenton, S Nielsen, J Frøkiær Aquaporins, 95-132, 2009 | 83 | 2009 |
| Role of multiple phosphorylation sites in the COOH-terminal tail of aquaporin-2 for water transport: evidence against channel gating HB Moeller, N MacAulay, MA Knepper, RA Fenton American Journal of Physiology-Renal Physiology 296 (3), F649-F657, 2009 | 81 | 2009 |
| Vasopressin-dependent short-term regulation of aquaporin 4 expressed in Xenopus oocytes HB Moeller, RA Fenton, T Zeuthen, N Macaulay Neuroscience 164 (4), 1674-1684, 2009 | 77 | 2009 |
| Phosphorylation and ubiquitylation are opposing processes that regulate endocytosis of the water channel aquaporin-2 HB Moeller, TS Aroankins, J Slengerik-Hansen, T Pisitkun, RA Fenton Journal of cell science 127 (14), 3174-3183, 2014 | 68 | 2014 |
| Chronic diarrhoea following surgery for colon cancer—frequency, causes and treatment options J Yde, HM Larsen, S Laurberg, K Krogh, HB Moeller International journal of colorectal disease 33, 683-694, 2018 | 57 | 2018 |
| New insights into regulated aquaporin-2 function RA Fenton, CN Pedersen, HB Moeller Current opinion in nephrology and hypertension 22 (5), 551-558, 2013 | 56 | 2013 |
| CHIP regulates aquaporin-2 quality control and body water homeostasis Q Wu, HB Moeller, DA Stevens, R Sanchez-Hodge, G Childers, ... Journal of the American Society of Nephrology 29 (3), 936-948, 2018 | 55 | 2018 |
| Identification of phosphorylation-dependent binding partners of aquaporin-2 using protein mass spectrometry NA Zwang, JD Hoffert, T Pisitkun, HB Moeller, RA Fenton, MA Knepper Journal of proteome research 8 (3), 1540-1554, 2009 | 55 | 2009 |
| Recent discoveries in vasopressin-regulated aquaporin-2 trafficking RA Fenton, HB Moeller Progress in brain research 170, 571-579, 2008 | 46 | 2008 |
| Renal aquaporins and water balance disorders HB Moeller, CH Fuglsang, RA Fenton Best Practice & Research Clinical Endocrinology & Metabolism 30 (2), 277-288, 2016 | 45 | 2016 |
Trairak Pisitkun, MDChief Medical Officer, Seqker Biosciences, Inc.Verified email at nhlbi.nih.gov
